Get the Stockscreener App
5.68
0.00%
0.00
After Hours:
5.68
Anavex Life Sciences Corporation stock is traded at $5.68, with a volume of 502.89K.
It is up +0.00% in the last 24 hours and down -5.65% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.
See More
Previous Close:
$5.68
Open:
$5.65
24h Volume:
502.89K
Relative Volume:
0.53
Market Cap:
$481.64M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-8.6061
EPS:
-0.66
Net Cash Flow:
$-29.31M
1W Performance:
+3.46%
1M Performance:
-5.65%
6M Performance:
+11.59%
1Y Performance:
-13.28%
1-Day Range:
$5.56
$5.88
1-Week Range:
$5.4012
$5.88
52-Week Range:
$3.25
$10.45
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Anavex Life Sciences Corporation [AVXL] Director makes an insider acquire of 2,835 shares worth 10,319. - Knox Daily
Australian Vanadium gets interest for $31 million finance support - Mining.com.au
AVXL Shares Experience Surge in Value - Knox Daily
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near? - Yahoo Finance
Australian Vanadium receives Letter of Interest for US$31 million in debt financing from EXIM - Proactive Investors UK
Ratios Revealed: Decoding Anavex Life Sciences Corporation (AVXL)’s Financial Health - The Dwinnex
Oops! Disney May Have Just Spoiled their Next Marvel Series - Bleeding Fool
A better buy-in window may exist right now for Anavex Life Sciences Corporation (AVXL) - SETE News
AVXL’s Market Balancing Act: Weighing Gains and Losses in 2023 - The InvestChronicle
Investing in Anavex Life Sciences Corporation (AVXL) might be a great opportunity, but the stock is a bit overvalued - US Post News
Anavex Life Sciences Corporation (AVXL) receives a Neutral rating from Cantor Fitzgerald - Knox Daily
Market Recap: Anavex Life Sciences Corporation (AVXL)’s Positive Momentum, Closing at 5.21 - The Dwinnex
AVXL Stock Sees Decline of Approximately -8.72% in Last Five Days - Knox Daily
Investors in cash trouble should check out Anavex Life Sciences Corporation (AVXL) - SETE News
Ratios Reveal: Breaking Down Anavex Life Sciences Corporation (AVXL)’s Financial Health - The Dwinnex
Investing in Anavex Life Sciences Corporation (AVXL): What You Must Know - Knox Daily
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire Inc.
A History of Outperforming Analyst Forecasts and Beating the Odds: Anavex Life Sciences Corporation (AVXL) - SETE News
Recent Insider Activity Could Benefit Anavex Life Sciences Corporation (AVXL) - Knox Daily
Market Watch Highlights: Anavex Life Sciences Corporation (AVXL) Ends on an Upturn Note at 6.02 - The Dwinnex
Should investors be concerned about Anavex Life Sciences Corporation (AVXL)? - US Post News
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 - StockTitan
Anavex Life Sciences Corporation (AVXL) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Anavex Life Sciences Corporation [NASDAQ: AVXL] Sees Increase in Stock Value - Knox Daily
Was anything positive for Anavex Life Sciences Corporation (AVXL) stock last session? - US Post News
Market Recap Check: Anavex Life Sciences Corporation (AVXL)’s Positive Finish at 6.36, Up/Down 0.63 - The Dwinnex
AVXL (Anavex Life Sciences Corporation) may reap gains as insiders became active recently - Knox Daily
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - AccessWire
NASDAQ: AVXL Lawsuit Update: Investors Who Lost Money With Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) Should Contact the Shareholders Foundation - Newswire
Anavex Life Sciences Corporation (AVXL)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Anavex Life Sciences (FRA:12X1) Enterprise Value : €357.17 Mil (As of Aug. 20, 2024) - GuruFocus.com
Analysts review Anavex Life Sciences Corporation’s rating - Knoxdaily.com
Market Recap: Anavex Life Sciences Corporation (AVXL)’s Negative Momentum, Closing at 6.09 - The Dwinnex
AVXL (Anavex Life Sciences) Financial Strength : 9 (As of Jun. 2024) - GuruFocus.com
Anavex Life Sciences (LTS:0HFR) Enterprise Value : $377.65 Mil (As of Aug. 18, 2024) - GuruFocus.com
California State Teachers Retirement System Sells 3,833 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (FRA:12X1) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com
AVXL (Anavex Life Sciences) 3-Year EPS without NRI Growth R - GuruFocus.com
AVXL (Anavex Life Sciences) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com
AVXL (Anavex Life Sciences) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com
Anavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest Update - MarketBeat
Anavex Life Sciences (FRA:12X1) Earnings per Share (Diluted) : €-0.47 (TTM As of Jun. 2024) - GuruFocus.com
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 5.7% - MarketBeat
Anavex Life Sciences Corporation (AVXL) can make a big difference with a little luck - SETE News
A year in review: Anavex Life Sciences Corporation (AVXL)’s performance in the last year - US Post News
Anavex Life Sciences Corporation’s latest rating changes from various analysts - Knox Daily
Analyzing Ratios: Anavex Life Sciences Corporation (AVXL)’s Financial Story Unveiled - The Dwinnex
Vanguard Group Inc. Grows Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
AVXL Stock Sees Decline of Approximately -10.52% in Last Five Days - Knox Daily
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 6.9% - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Releases Quarterly Earnings Results - MarketBeat
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):